3/21/2024 | 30044940 | LAMBROTIN SYRUP 15 MG+2.5MG/5 ML 100 ML(PB) - MFG D- 27/1/24 EXP D- 26/1/27 BATCH NO- LM2-71, 72, LM1-23 | XXXXXXXXXX | 48812 | PCS | 18800.53 | TAJIKISTAN | PIYALA ICD |
3/21/2024 | 30044940 | LAMBROTIN SYRUP 15 MG+2.5MG/5 ML 100 ML(PB) - MFG D- 27/1/24 EXP D- 26/1/27 BATCH NO- LM2-71, 72, LM1-23 | XXXXXXXXXX | 48812 | PCS | 18800.53 | TAJIKISTAN | PIYALA ICD |
3/1/2024 | 30044940 | LAMBROTIN SYRUP 15MG+2.5 MG /5ML 100 ML(PB) - MFG D- 22/12/2023 EXP D- 21/12/2026 BATCH NO- LM2-68 | XXXXXXXXXX | 19710 | PCS | 6575.87 | TAJIKISTAN | PIYALA ICD |
12/13/2023 | 30044940 | CABERGONE (CABERGOLINE TABLETS USP)BATCH NO.E3S2GTA026MFG.DT.SEP-23 & EXP.DT.AUG-2630 | XXXXXXXXXX | 12800 | PCS | 12693.9 | GEORGIA | DELHI ACC |
12/11/2023 | 30044940 | LAMBROTIN SYRUP 30 MG+5 MG/5 ML 100 ML (PB) #1 - MFG D- 25-10-2023 ,EXP D- 24-10-2026 BATCH# LBT2-52, LBT2-5330 | XXXXXXXXXX | 39087 | NOS | 15272.62 | TAJIKISTAN | PIYALA ICD |
12/11/2023 | 30044940 | LAMBROTIN SYRUP 15 MG+2.5 MG/5 ML 100 ML(PB) #1 - MFG D- 1-10-2023 ,EXP D- 31-10-2026 BATCH# LM2-64, LM2-65, LM2-6630 | XXXXXXXXXX | 58670 | NOS | 17280.55 | TAJIKISTAN | PIYALA ICD |
11/29/2023 | 30044940 | CABGOL 0.5 Batch No.:E3S2GTA015 Mfg. date: AUG-2023, Exp. Date: JUL-2026 (Cabergoline Tablets USP 0.5 mg) | XXXXXXXXXX | 15000 | NOS | 6484.93 | AFGHANISTAN | TUGLAKABAD ICD |
11/23/2023 | 30044940 | LAMBROTIN SYRUP 30 MG+5 MG/5 ML 100 ML (PB) #1 - MFG DT - 13.9.2023, EXP DT- 12.9.2026 BATCH# LBT2-49, 50, 51 | XXXXXXXXXX | 58920 | NOS | 20571.63 | TAJIKISTAN | PIYALA ICD |
10/29/2023 | 30044940 | LAMBROTIN SYRUP 30 MG+5 MG/5 ML 100 ML (PB) #1- MFG D-27/7/23 EXP D-26/7/26, BATCH# LBT1-16 | XXXXXXXXXX | 4920 | NOS | 1778.2 | Kyrgyzstan | PIYALA ICD |
10/8/2023 | 30044940 | LAMBROTIN SYRUP 15 MG+2.5 MG/5 ML 100 ML(PB) #1 - MFG D- 17/05/2023 EXP DT- 16/05/2026 BATCH# LM1-20 | XXXXXXXXXX | 4788 | NOS | 1393.73 | Kyrgyzstan | PIYALA ICD |